Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations

Regulatory changes have been enacted in the United States (US) and European Union (EU) to encourage the development of new treatments for pediatric cancer. Here, we review some of the factors that have hampered the development of pediatric cancer treatments and provide a comparison of the US and EU...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Paediatr Drugs
Autori principali: Barry, Elly, Walsh, Jaimie A., Weinrich, Scott L., Beaupre, Darrin, Blasi, Eileen, Arenson, Daniel R., Jacobs, Ira A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2021
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275539/
https://ncbi.nlm.nih.gov/pubmed/34173206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-021-00455-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi